173 related articles for article (PubMed ID: 35769151)
1. Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study.
Ye J; Hu S; Zhang W; Zhang D; Zhang Y; Yu D; Peng J; Xu J; Wei Y
Front Surg; 2022; 9():893429. PubMed ID: 35769151
[TBL] [Abstract][Full Text] [Related]
2. Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study.
Wang S; Hu S; Huang S; Su L; Guo Q; Wu B; Ye J; Zhang D; Zhang Y; Zhang W; Wei Y
Medicine (Baltimore); 2023 Feb; 102(6):e32772. PubMed ID: 36820587
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of lung squamous cell carcinoma patients with second primary malignancies: a SEER database study.
Han W; Wang S; Su L; Xu J; Wei Y
Front Oncol; 2024; 14():1294383. PubMed ID: 38444672
[TBL] [Abstract][Full Text] [Related]
4. Analysis of prognosis and treatment decisions for patients with second primary lung cancer following esophageal cancer.
Li JL; Li H; Wu Q; Zhou H; Li Y; Li YH; Li J
Front Oncol; 2022; 12():777934. PubMed ID: 36052233
[TBL] [Abstract][Full Text] [Related]
5. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
6. The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study.
Hong J; Wei R; Nie C; Leonteva A; Han X; Du X; Wang J; Zhu L; Tian W; Zhou H
Future Oncol; 2021 Nov; 17(33):4497-4509. PubMed ID: 34402680
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
Wang W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
[TBL] [Abstract][Full Text] [Related]
8. Second primary malignancies among cancer patients.
Zheng X; Li X; Wang M; Shen J; Sisti G; He Z; Huang J; Li YM; Wu A;
Ann Transl Med; 2020 May; 8(10):638. PubMed ID: 32566575
[TBL] [Abstract][Full Text] [Related]
9. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
10. The influence of adjuvant radiation therapy after endoscopic resection on survival for early stage EC: an analysis of the surveillance epidemiology and end results (SEER) database.
Chen B; Lin J; Ruan Y; Chen Z; Petersen K; Kong M; Shen J; Wang G
J Thorac Dis; 2019 Aug; 11(8):3427-3434. PubMed ID: 31559047
[TBL] [Abstract][Full Text] [Related]
11. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
12. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
[TBL] [Abstract][Full Text] [Related]
13. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Bian X; He X; Yang L; Wu W; Li L
Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features and prognosis of patients with esophageal cancer as the second primary cancer: a large population-based analysis using the SEER program [2000-2015].
Chen Z; Li M; Ma K; Hu Z; Wang S; Chen H; Zheng Y; Zhan C; Lin Z; Wang Q
Transl Cancer Res; 2020 Feb; 9(2):1113-1124. PubMed ID: 35117455
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prognostic factors of esophageal cancer between a Chinese cohort and the Surveillance, Epidemiology, and End Results (SEER) database: a retrospective cohort study.
Hu B; Zhu Y; Wu X
J Gastrointest Oncol; 2022 Apr; 13(2):527-538. PubMed ID: 35557583
[TBL] [Abstract][Full Text] [Related]
17. Second primary malignancy among malignant solid tumor survivors aged 85 years and older.
Zhang Z; Liu F; Qu Y; Qiu L; Zhang L; Yang Q
Sci Rep; 2021 Oct; 11(1):19748. PubMed ID: 34611235
[TBL] [Abstract][Full Text] [Related]
18. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
19. Second Primary Malignancy Risk in Multiple Myeloma from 1975 to 2018.
Wang J; Lv C; Zhou M; Xu JY; Chen B; Wan Y
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230842
[TBL] [Abstract][Full Text] [Related]
20. Long-term radiation therapy-related risk of second primary malignancies in patients with lung cancer.
Han C; Wu Y; Kang K; Wang Z; Liu Z; Zhang F
J Thorac Dis; 2021 Oct; 13(10):5863-5874. PubMed ID: 34795935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
